Dishman Carbogen Amcis Ltd
NSE:DCAL

Watchlist Manager
Dishman Carbogen Amcis Ltd Logo
Dishman Carbogen Amcis Ltd
NSE:DCAL
Watchlist
Price: 267.9 INR -0.73%
Market Cap: 42B INR
Have any thoughts about
Dishman Carbogen Amcis Ltd?
Write Note

Dishman Carbogen Amcis Ltd
Long-Term Investments

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Dishman Carbogen Amcis Ltd
Long-Term Investments Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Long-Term Investments CAGR 3Y CAGR 5Y CAGR 10Y
Dishman Carbogen Amcis Ltd
NSE:DCAL
Long-Term Investments
â‚ą1.1B
CAGR 3-Years
17%
CAGR 5-Years
-5%
CAGR 10-Years
N/A
Divi's Laboratories Ltd
NSE:DIVISLAB
Long-Term Investments
â‚ą820m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Suven Life Sciences Ltd
NSE:SUVEN
Long-Term Investments
â‚ą486k
CAGR 3-Years
N/A
CAGR 5-Years
-82%
CAGR 10-Years
N/A
Syngene International Ltd
NSE:SYNGENE
Long-Term Investments
â‚ą1.1B
CAGR 3-Years
-26%
CAGR 5-Years
-21%
CAGR 10-Years
N/A
Vimta Labs Ltd
NSE:VIMTALABS
Long-Term Investments
â‚ą28m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
I
Innova Captab Ltd
NSE:INNOVACAP
Long-Term Investments
â‚ą10k
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Dishman Carbogen Amcis Ltd
Glance View

Market Cap
42B INR
Industry
Life Sciences Tools & Services

Dishman Carbogen Amcis Ltd. is a manufacturing company, which engages in the provision of outsourcing services for the pharmaceutical industry. The company is headquartered in Ahmedabad, Gujarat. The company went IPO on 2017-09-21. The firm's segments include CRAMS and Vitamin - D, Bulk Drugs, Quats, Specialty Chemicals and traded goods. The firm assists pharma companies through various stages of drug development from process research and development to late-stage clinical and commercial manufacturing facilities, along with the supply of active pharmaceutical ingredients (APIs) and intermediates. The firm has manufacturing and research facilities in India, Switzerland, France, Netherlands, United Kingdom and China. The firm's subsidiaries include CARBOGEN AMCIS (Shanghai) Co. Ltd, Dishman Infrastructure Ltd., Dishman Carbogen Amcis (Singapore) Pte. Ltd., CARBOGEN AMCIS Holding AG and Dishman Biotech Ltd.

DCAL Intrinsic Value
257.4 INR
Overvaluation 4%
Intrinsic Value
Price

See Also

What is Dishman Carbogen Amcis Ltd's Long-Term Investments?
Long-Term Investments
1.1B INR

Based on the financial report for Sep 30, 2024, Dishman Carbogen Amcis Ltd's Long-Term Investments amounts to 1.1B INR.

What is Dishman Carbogen Amcis Ltd's Long-Term Investments growth rate?
Long-Term Investments CAGR 5Y
-5%

Over the last year, the Long-Term Investments growth was 10%. The average annual Long-Term Investments growth rates for Dishman Carbogen Amcis Ltd have been 17% over the past three years , -5% over the past five years .

Back to Top